A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome)
Objective. To evaluate the efficacy and safety of Yi Qi Gu Biao (YQGB) pill in treating frequent exacerbator phenotype in chronic obstructive pulmonary disease (lung and spleen qi deficiency syndrome) (FEPCOPD). Methods. This prospective, randomized, double-blind, controlled study assessed 112 cases...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/9130804 |
id |
doaj-df8e4ebfaa4646ffb192ef2bdb6e0df8 |
---|---|
record_format |
Article |
spelling |
doaj-df8e4ebfaa4646ffb192ef2bdb6e0df82020-11-24T23:03:38ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882017-01-01201710.1155/2017/91308049130804A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome)Gao Zhen0Jing Jing1Xu Dan2Li Zheng3Li Fengsen4Sun Qi5National Clinical Research Base of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, ChinaNational Clinical Research Base of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, ChinaNational Clinical Research Base of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, ChinaNational Clinical Research Base of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, ChinaNational Clinical Research Base of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, ChinaNational Clinical Research Base of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, ChinaObjective. To evaluate the efficacy and safety of Yi Qi Gu Biao (YQGB) pill in treating frequent exacerbator phenotype in chronic obstructive pulmonary disease (lung and spleen qi deficiency syndrome) (FEPCOPD). Methods. This prospective, randomized, double-blind, controlled study assessed 112 cases (64 included) of FEPCOPD treated at the outpatient department in our hospital in January–August 2016. The patients were randomly divided into YQGB and placebo (Pb) and treated for three months. Lung function, CAT, mMRC, and TCM symptom scores (TCMs) were observed. Results. Compared with Pb, YQGB showed decreased wheezing symptom scores (WSs) and TCMs at one month and decreased CAT and TCMs at three months. From one to three months, CAT, cough, sputum, WSs, and TCMs in YQGB were lower than pretreatment values. But in Pb, CAT was lower than pretreatment values after one month; CAT, sputum, and TCMs were lower than pretreatment values after two months; CAT, cough, sputum, WSs, and TCMs were lower than pretreatment values after three months. Conclusion. Yi Qi Gu Biao pill can improve wheezing, health status, and TCMs in FEPCOPD and also can shorten the durations of cough, sputum, and wheezing. This trial is registered in the Clinical Trials Registry of China: ChiCTR-IOR-15007542 (on 8 December 2015).http://dx.doi.org/10.1155/2017/9130804 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gao Zhen Jing Jing Xu Dan Li Zheng Li Fengsen Sun Qi |
spellingShingle |
Gao Zhen Jing Jing Xu Dan Li Zheng Li Fengsen Sun Qi A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome) Evidence-Based Complementary and Alternative Medicine |
author_facet |
Gao Zhen Jing Jing Xu Dan Li Zheng Li Fengsen Sun Qi |
author_sort |
Gao Zhen |
title |
A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome) |
title_short |
A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome) |
title_full |
A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome) |
title_fullStr |
A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome) |
title_full_unstemmed |
A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome) |
title_sort |
randomized controlled study of the yi qi gu biao pill in the treatment of frequent exacerbator phenotype in chronic obstructive pulmonary disease (lung and spleen qi deficiency syndrome) |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2017-01-01 |
description |
Objective. To evaluate the efficacy and safety of Yi Qi Gu Biao (YQGB) pill in treating frequent exacerbator phenotype in chronic obstructive pulmonary disease (lung and spleen qi deficiency syndrome) (FEPCOPD). Methods. This prospective, randomized, double-blind, controlled study assessed 112 cases (64 included) of FEPCOPD treated at the outpatient department in our hospital in January–August 2016. The patients were randomly divided into YQGB and placebo (Pb) and treated for three months. Lung function, CAT, mMRC, and TCM symptom scores (TCMs) were observed. Results. Compared with Pb, YQGB showed decreased wheezing symptom scores (WSs) and TCMs at one month and decreased CAT and TCMs at three months. From one to three months, CAT, cough, sputum, WSs, and TCMs in YQGB were lower than pretreatment values. But in Pb, CAT was lower than pretreatment values after one month; CAT, sputum, and TCMs were lower than pretreatment values after two months; CAT, cough, sputum, WSs, and TCMs were lower than pretreatment values after three months. Conclusion. Yi Qi Gu Biao pill can improve wheezing, health status, and TCMs in FEPCOPD and also can shorten the durations of cough, sputum, and wheezing. This trial is registered in the Clinical Trials Registry of China: ChiCTR-IOR-15007542 (on 8 December 2015). |
url |
http://dx.doi.org/10.1155/2017/9130804 |
work_keys_str_mv |
AT gaozhen arandomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT jingjing arandomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT xudan arandomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT lizheng arandomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT lifengsen arandomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT sunqi arandomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT gaozhen randomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT jingjing randomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT xudan randomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT lizheng randomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT lifengsen randomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome AT sunqi randomizedcontrolledstudyoftheyiqigubiaopillinthetreatmentoffrequentexacerbatorphenotypeinchronicobstructivepulmonarydiseaselungandspleenqideficiencysyndrome |
_version_ |
1725632954503266304 |